Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 68 of 95, showing 5 Applications out of 474 total, starting on record 336, ending on 340

# Protocol No Study Title Investigator(s) & Site(s)

336.

ECCT/10/11/06   Randomized Comparison of ART Alone versus ART with Immediate Chemotherapy
    A5264/AMC 067 "A Randomized Evaluation of Antiretroviral Therapy Alone or with Delayed Chemotherapy versus Antiretroviral Therapy with Immediate Adjunctive Chemotherapy for Treatment of Li1mited Stage AIDS-KS in Resource-Limited Settings (REACT-KS)"   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Walter Reed Project Kericho (Kericho county)
2. Moi University Clinical Research Centre (Uasin Gishu county)
 
View

337.

ECCT/12/04/03   SELECT (SEcond-Line Effective Combination Therapy)
    A5273: Multicenter Study of Options for SEcond-Line Effective Combination Therapy (SELECT)   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
Moi University Clinical Research Centre
 
View

338.

ECCT/11/07/02   REMEMBER
    A5274/REMEMBER "Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment Regimens"   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. Walter Reed Project (Kericho county)
 
View

339.

ECCT/12/04/02   Short-course RPT/INH for latent TB in HIV-infected individuals
    A5279: Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals with Latent Tuberculosis Infection       
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
 
View

340.

ECCT/12/11/03   Rifampin-Based TB Treatment vs. Rifabutin-Based TB Treatment in HIV
    A5290 "A Randomized, Phase 2b Study of a Double-Dose Lopinavir/Ritonavir-Based Antiretroviral Regimen with Rifampin-Based Tuberculosis Treatment versus a Standard-Dose Lopinavir/Ritonavir-Based Antiretroviral Regimen with Rifabutin-Based Tuberculosis Treatment with or without Raltegravir in HIV-1-Infected Persons Requiring Treatment for Active TB and HIV"          
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
 
View